Physician Education: Bridging Clinical Research and Patient Care

Faculty Profile

President
Global Strategies for HIV Prevention
San Rafael, CA

Topics of Professional Interest:
  • Perinatal HIV transmission
  • Pediatric HIV infection
  • Immunology of HIV
Current Professional Summary:

Dr Ammann is President of Global Strategies for HIV Prevention. He is also a Clinical Professor of Pediatric Immunology at the University of California San Francisco Center for AIDS Prevention, and Chairman of the Conference on Global Strategies for Prevention of HIV Transmission from Mothers to Infants.

Committees and Organizations:
  • Member, Presidential National AIDS Task Force on Drug and Vaccine Development (1994)
Honors and Awards:
  • Burton Lectureship Award, American Academy of Pediatrics (1987)
  • Selected as one of "The POZ 50," persons who have most influenced the course of HIV/AIDS (1994)
  • Outstanding Research in Pediatric AIDS Award, AmFAR, presented on World AIDS Day (1995)
  • Tamil Nadu, Dr MGR Medical University, Visiting Professor/Professor Emeritus in recognition of contributions to HIV/AIDS internationally (1997)
  • Honorary Professor, Chinese National Academy of Sciences (2000)
Education:
  • Wheaton College, BS Biology (1958)
  • New Jersey College of Medicine, MD (1962)
  • Jersey City Medical Center, Internship (1962–1963)
  • University of California San Francisco, Residency in Pediatrics (1963–1965)
  • University of California San Francisco, Chief Resident (1965–1966)
  • University of Minnesota Medical Center, Fellowship in Immunology (1968–1969)
  • University of Wisconsin Medical Center, Fellowship in Immunology (1969–1971)
Selected Publications:
  1. Ammann AJ. Unrestricted routine prenatal HIV testing: the standard of care. Journal of the American Medical Women's Association. 1995;50:83-84.
  2. Nielsen K, McSherry G, Petru A, Frederick T, Wara D, Bryson Y, Martin N, Hutto C, Ammann AJ, Grubman S, Oleske J, Scott G. A descriptive survey of pediatric human immunodeficiency virus-infected long-term survivors. Pediatrics. 1997;99:1-7.
  3. Cao Y, Krogstad P, Korber BT, Koup RA, Muldoon M, Macken C, Song J-L, Jin Z, Zhao J-Q, Clapp S, Chen ISY, Ho DD, Ammann AJ, and the Ariel Project Investigators. Maternal HIV-1 viral load and vertical transmission of infection: the Ariel Project for the prevention of HIV transmission from mother to infant. Nat Med. 1997;3:549-552.
  4. Wilson CC, Brown RC, Korber BT, Wilkes BM, Ruhl DJ, Sakamoto D, Kunstman K, Luzuriaga K, Hanson CI, Widmayer S, Siznia A, Clapp S, Ammann AJ, Koup R, Wolinsky SM, Walker BD, and the Ariel Project Investigators. Frequent detection of escape from cytotoxic T lymphocyte recognition in perinatal HIV-1 transmission: the Ariel Project for the prevention of HIV transmission from mothers to infants. J Virol. 1999;73:3975-3985.
  5. Perinatal HIV Intervention Research in Developing Countries Workshop Participants. Ammann AJ, et al. Science, ethics and the future of research into maternal infant transmission of HIV-1. Lancet. 1999;353:832-835.
  6. Ammann AJ, et al. International AIDS Society position paper on prevention of HIV-1 mother to child transmission. International AIDS Society Newsletter. 1999;13:5-9.
  7. Polycarpou A, Ntais C, Korber BT, et al. Association between maternal and infant class I and II HLA alleles and of their concordance with the risk of perinatal HIV type 1 transmission. AIDS Res Hum Retroviruses. 2002;18:741-746.
  8. Perez-Then E, Pena R, Tavarez-Rojas M, Pena C, Quinonez S, Buttler M, Ammann A, Hernandez W, Goyanes M, Miguez MJ, Shor-Posner G; PMTCT Group. Preventing mother-to-child HIV transmission in a developing country: the Dominican Republic experience. J Acquir Immune Defic Syndr. 2003;34:506-511.